$ Value
$0
Shares
54,166
Price
$0
Filed
Jan 5
Insider
Name
Donley Matthew Maxwell
Title
Chief Operating Officer
CIK
0001636642
Roles
Transaction Details
Transaction Date
2026-01-02
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
734,631
Footnotes
Represents the number of shares earned upon certification of performance for a performance award payable solely in common shares of the Issuer that vest in two (2) equal annual installments on December 31, 2025 and December 31, 2026. | Represents shares withheld to satisfy tax withholding obligations upon the vesting of performance awards. | Includes common shares acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 2,500 common shares were acquired on May 30, 2025 and 1,457 common shares were acquired on November 28, 2025.
Filing Info
Donley Matthew Maxwell's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-02 | AUPH | F | $579K |
| 2026-02-27 | AUPH | A | $0 |
| 2026-02-27 | AUPH | A | $0 |
| 2026-02-20 | AUPH | F | $474K |
| 2026-01-02 | AUPH | A | $0 |
| 2026-01-02 | AUPH | F | $682K |
Other Insiders at AUPH (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| TANG KEVIN | $12.7M | — | 2026-03-03 |
|
Greenleaf Peter
Chief Executive Officer
|
— | — | 2026-03-02 |
|
Donley Matthew Maxwell
Chief Operating Officer
|
— | — | 2026-03-02 |
|
Miller Joseph M
Chief Financial Officer
|
— | — | 2026-03-02 |
|
Robertson Stephen P.
EVP, General Counsel
|
— | — | 2026-03-02 |
|
Keenan Greg
SVP, Chief Medical Officer
|
— | — | 2026-03-06 |